Bacteriologists of the 19th century were aware of the host's capacity to overcome bacterial and other types of infection and their capacity to resist further infections. Early theories of immunity were particularly concerned with circulating antibodies and their mode of interaction with, and elimination of, infective agents. These studies identified a number of ways in which host factors were able to destroy invading organisms. Such mechanisms included direct bacterial lysis by antibody, usually occurring in association with complement and, under other conditions, agglutination of bacteria, which rendered them more susceptible to the phagocytic action of macrophages and polymorphs. More subtle changes could sometimes be demonstrated where antibody reacting with the antiphagocytic outer coating ofcertain capsulated bacteria also predisposed them to phagocytosis.
Early bacteriologists were also aware that protection was sometimes provided when no antibodies could be demonstrated. Early classic studies on infections caused by Mycobacterium tuberculosis demonstrated the importance of lymphocytes in protective immunity against certain organisms, and it is now known that suitably sensitized lymphocytes are able to cause direct cytotoxic effects on cells as well as to secrete a range of lymphokines, affecting many different components of the inflammatory response which may aid, directly or indirectly, antigen elimination.
During early years, most attention was focussed upon circulating factors promoting antigen elimination, particularly as they influenced systemic rather than local infections.
Around the turn of the century, studies were performed which demonstrated the antibacterial inhibitory properties of various external secretions, but techniques were not available at that time to distinguish between specific antibody, natural antibody or nonimmunological antimicrobial activity (now known to include such substances as lysozyme, lactoferrin, and interferon). Marc Daniels lecture at the Royal College of Physicians Some of the milestones in the advance of our knowledge concerning local protection of surfaces exposed to the outside environment are worth recalling, because they emphasize the fundamental distinction between immunological protection from surface invaders and the immunological processes responsible for the elimination of damaging organisms which have already gained access to the internal environment of the body.
For example, as early as 1919, Besredka demonstrated that the oral administration of enterobacteria could successfully afford protection from the damaging effects of a further bacterial challenge, and Davies in 1922 was able to show that specific antibodies to Shigella could be found in the stools of patients recovering from dysentery.
The classic experiments of Burrows and Havens in 1948, studying cholera in pigs, showed that the degree of immunity was related to the titre of antibody found in the faeces (coproantibody) and correlated poorly with serum antibody levels. They showed that parenteral inoculation of organisms gave protection against parenteral infection, but protection from an oral challenge with cholera was obtained only if coproantibodies (local antibody) were present.
Early studies on the respiratory tract were made by Bull and McKee (1929) , who showed in rabbits that immunity to further challenge by pneumococci administered by the nasal route was associated with mucoantibodies detectable in the nasal secretions. Only some 20 years ago were detailed studies on the respiratory tract undertaken. Fazekas de St. Groth (1950) , using mice, showed that, following instillation of influenza virus antigen into the nose, the ratio of antibody in the nasal secretions to that found in the serum was 10 times greater than that following the subcutaneous injection of virus. They also demonstrated a strong positive correlation between haemagglutinating activity of bronchial washing sand the degree of specific immunity. They Tomasi (1963) , and that plasma cells in the lamina propria were mainly of t-he IgA type was shown a few years later (Tomasi et al., 1965; Tourville et al., 1969) .
Over the past decade a large amount of information has accumulated concerning secretory immunoglobulins in general, and several detailed and excellent reviews have been published (Secretory Immunologic System, 1971; Tomasi and Grey, 1972) . However, much information is still needed concerning protective immunity of the respiratory tract in man and its implications in clinical respiratory medicine.
One of the reasons why study of protective local immunity of the respiratory tract has been relatively neglected may in part be due to the exciting developments in other fields of immunology, particularly immunopathogenesis or the tissue-damaging processes induced by various types of antibody and sensitized cells. This field of study was stimulated, at about the same time as the discovery of secretory IgA, by the now classic classification proposed by Gell and Coombs (1968) and its application in the field of respiratory medicine, particularly by Pepys (1969) .
Theories about immunopathogenesis of disease, however, have often failed to answer the very important questions as to why only a small proportion of an exposed population develop hypersensitivity reactions to infective or non-infective agents and what immune responses protect the majority.
The object of this Marc Daniels lecture is to review certain aspects of protective immunity of the respiratory tract studied over the past decade in the hope that this will stimulate further systematic clinical work which is now long overdue.
The respiratory defences against external agents are multiple; they involve specific and non-specific mechanisms and include physical as well as humoral and cellular mechanisms of defence (Fig. 1) (Walton, 1970; Muir, 1972) .
NON-SPECIFIC HUMORAL AGENTS
A variety of non-immunological chemical substances are found in bronchial secretions, and these are probably derived from bronchial glands or epithelial cells. They include lysozyme capable of lysing bacteria, particularly in the presence of complement (Inoue et al., 1959 ) and lactoferrin, a glycoprotein which binds iron and is bacteriostatic to certain bacteria (Masson et al., 1966) .
Interferon is another protein substance of low molecular weight which may be detected in both serum and respiratory secretions and is stimulated especially by viruses, bacteria, and endotoxins and has recently been observed following injection of transfer factor from peripheral lymphocytes (Emodi, Just, and Grob, 1973 The site of origin of secretory piece is somewhat controversial because many antibodies prepared against secretory piece cross-react with lactoferrin. However, the general view is that this is formed in the epithelial cells of bronchial glands (Fig. 4) and becomes attached to IgA produced from local plasma cells either as this is transported through the epithelial cells or after it has been secreted in the bronchial lumen.
Secretory IgA has been shown to be stimulated locally by intranasal inoculation of various respiratory viruses (Artenstein, Bellanti, and Buescher, 1964; Chanock et al., 1966; Smith et al., 1966 and Smith, Bellanti, and Chanock, 1967; Alford et This is evidence that the secretory IgA system is at least partially independent of serum IgA (especially when challenged locally) and is chemically distinct. Although some controversy continues, secretory IgA is more stable than serum IgA in the presence of a number of agents, including proteolytic enzymes (Brown, Newcombe, and Ishizaka, 1970) , and should therefore be more capable of retaining its immunological capacity in the presence of lytic enzymes when the latter are secreted, for instance from local pus cells. Further, secretory IgA in the presence of lysozyme and complement is able to cause bacterial lysis, whereas serum IgA is probably non-complement fixing by the classic pathway and has no such lytic action (Adinolfi et al., 1966; Ishizaka et al., 1966) .
On the evidence of experimental challenge with viruses and bacteria, the case for stimulation of local specific antibody of the IgA class in secretions appears to be substantiated. (South et al., 1965; Tomasi, 1968) . However, where there is a partial deficiency only, then there may be a disparity between deficient serum levels and relatively normal secretory levels. This has been described in a case of malabsorption syndrome (Swanson et al., 1968) and in ataxia telangiectasis (McFarlin et al., 1965) . This disparity will be exemplified later when asthma and bronchitis are discussed.
The disparity between low serum levels and normal secretory levels may be particularly important in explaining the finding of isolated IgA deficiencies in about 1 in 600 healthy adults (Bachmann, 1968 (Stobo and Tomasi, 1967 (Table 1) , and the main respiratory disorders could be classified into five groups: recurrent infections, asthma, lymphomas, sarcoidosis, and miscellaneous (Table 11) . Stobo and Tomasi (1967) have shown that in immune deficiency states, local IgG and IgM are produced and perhaps compensate for loss of IgA, but these immunoglobulins do not appear to be associated with secretory piece. IgM and IgG secretions into the respiratory tract may thus provide a replacement form of protection, but their lack of resistance to proteolytic enzymes might render them a poor substitute for IgA, and might also make their detection in bronchial secretions more difficult. IgG and IgM will nevertheless afford important protection from organisms once they have gained access to the body, and this may account for the rapid response to systemic infections, although the predisposition to recurrent infections continues. It also might account for the normal development of bacterial IgG precipitins seen in some of these cases, although we have noted the absence of such precipitins in other patients and this feature may be another manifestation of a more subtle form of immune deficiency in some patients; this defect might depend upon inadequate T cell cooperation or inadequate IgG antibody formation. The frequency of respiratory symptoms in isolated IgA deficiency, sometimes associated with an absent IgG response on immunization challenge, has been described previously by Hobbs (1968) .
Isolated IgA deficiencies are also seen rarely and sometimes apparently as an acquired disorder in association with a number of diseases including lupus erythematosus, cirrhosis of the liver, malabsorption syndrome, including coeliac disease and cystic fibrosis, and asthma. This diverse list suggests that there is more than one cause for the low serum level. Moreover Early studies have emphasized the importance of H. influenzae as a pathogen in this condition (May, 1968) . Serum IgG precipitins to the Hi antigen of H. influenzae are very common in infective chronic bronchitis, occurring in some 69% of one series of cases reported by Burns and May (1967) , and relating to clinical exacerbations with purulent sputum. The role of circulating precipitins in defence mechanisms or hypersensitivity tissue-damaging responses is so far unestablished.
Recent work on immune responses in chronic bronchitis has included studies on IgA in the serum, IgA in the saliva (where secretory IgA can be measured without the complicating features of secondary infection and its associated pathology), and IgA in sputum which is relevant to the actual site of disease (see Fig 5) . (Siegler and Citron, 1974) . This incidence is more than twice as great as would be expected in a random population. IgA levels in saliva obtained after maximal stimulation of flow were found to lie within the normal range, having a normal mean value of 2-6 mg/dl. The relationship between the serum and salivary levels was not close although all of the cases with low serum IgA levels had salivary levels less than 4 mg/dl. Salivary IgA levels did not apparently differ in simple chronic bronchitis compared with the infected 'complicated' cases. From this study it appears that there is no abnormality affecting the entire secretory IgA system in chronic bronchitis. This conclusion supports the findings of Lewis, Lapp, and Burrell (1970) , studying saliva, and of Alford et al. (1967) , who found normal IgA levels in the nasal secretions of bronchitics.
SPUTUM Quantitative measurements of IgA in sputum are difficult to interpret partly because of the wide variation in the concentration in sputum obtained at different times and also because the contribution from serum through inflammatory exudate is variable and may be great.
To allow for these difficulties, Medici and Buergi (1971) graded the extent of inflammatory change by relating it to sputum lactate dehydrogenase levels and studied mild, moderate, and severe chronic bronchitics through infective exacerbations. In mild bronchitics, IgA levels were shown to increase with inflammation, but in advanced cases, the IgA levels were low initially and failed to rise at times of infection. Low IgA levels in sputum have also been reported in a small number of chronic bronchitics after allowance was made for serum contamination (Deuschl and Johannson, 1973) . On the other hand, Falk, Okinaka, and Siskind (1972) , using bronchial washings, were unable to demonstrate a difference in IgA production between controls and those with chronic airways obstruction.
PLASMA CELL COUNTS To overcome the problems of serum dilutional factors, a more direct approach has been to perform differential counts using immunofluorescent techniques on local plasma cells forming specific classes of immunoglobulin.
Preliminary data reported by Gerber, Paronetto, and Kochwa (1971) showed fewer IgA and IgG cells in random bronchial wall sections from bronchitics than in normals. Soutar (1974) Tada and Ishizaka (1970) .
In contrast to the normal, grossly reduced numbers of IgA plasma cells were found in the trachea and bronchus in advanced and fatal chronic bronchitis (Fig. 6) . In smokers without cough, an increase in IgA was demonstrated (Soutar and Turner-Warwick, 1974; Soutar, 1975) , and this finding correlates well with Medici and Buergi's data on sputum in mild and moderately severe bronchitis. An increased number of IgA plasma cells has also been observed in patients with cystic fibrosis and recurrent bronchial infections (Martinez-Tello, Braun, and Blanc, 1968 Medici and Buergi (1971) . Thus we may offer a tentative hypothesis on the sequence of events in chronic inflammation of the bronchi due to cigarette smoke (Fig. 7) . This hypothesis is based on the concept of an initial and a later deficiency in local IgA production, the initial depletion perhaps dependent on a water-soluble fraction from cigarettes (Roszman and Rogers, 1973) and the secondary depletion dependent on local changes in the mucosa. Clinical aspects of protective immunity of the respiratorv tract In our survey of patients seen over a two-year period with low IgA values, 14 had asthma, and of this small number eight had extrinsic and six intrinsic asthma (Table I) Callerame et al. (1971) found no depletion of IgA cells in bronchial wall plasma cell counts.
Further evidence of the normal local production of specific antibody in asthmatics has been demonstrated by Waldman, Newman, and Grunspan (1970) , who found that aerosol immunization with killed influenza vaccine in asthmatics was normal.
Preliminary studies in our laboratory have shown that in a few asthmatic patients with bronchorrhoea, secretory piece is present, and this contrasts with the findings in advanced bronchitis.
Normal antibacterial defences of the respiratory tract are also suggested indirectly by the early studies of Burns and May (1967) , who showed that only 6 % of asthmatics had precipitins to Hi antigen, presumably because these organisms were dealt with by effective local mechanisms before invasion occurred.
In advanced cases of chronic bronchitis with asthma, the situation may become more complicated. Not only do circulating precipitins increase, but there is some evidence to suggest that complement and IgG may be found in the basement membrane of the respiratory epithelium (Callerame et al., 1971; Gerber et al., 1971 A recent special opportunity to study the effects of corticosteroids on local defences has arisen with the use of beclomethasone diproprionate now frequently used in the treatment of asthma. Superficial candidiasis is very frequent (Brompton Hospital/MRC Trial, 1974) and has been reported in over 70 % of cases on high-dose, long-term therapy. Systemic invasion has not been reported, and the presence of this superficial infestation has not so far interfered with the management of asthma. Candidiasis occurs most frequently in those having pre-existing precipitins, suggesting that the superficial infection is an exacerbation of a pre-existing state; the appearance of precipitins for the first time after local oral thrush was also found, but much less frequently. The relationship between this and local antibody production is now being studied.
CONCLUSION
Much has yet to be learned about the precise immunological responses protecting the respiratory tract. The exact role of locally produced IgA antibody and its interdependence (if any) on antibody produced in local lymph nodes remains to be clarified.
Due to the multiple systems of non specific and immunologically specific defences, penetration by organisms to the internal environment of the body can be prevented even when one or another of these systems is grossly compromised.
An hypothesis has been presented that as these barriers are broken down, so circuits of local damage may become established, which not only result in further local disruption but will also themselves destroy other defences. 
